Kuros Biosciences AG (CSBTF) Financials

CSBTF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 119.5 million 47.9 million
Dec. 31, 2025 107.3 million 49.4 million
June 30, 2025 110.0 million 33.3 million
Dec. 31, 2024 84.5 million 25.8 million

CSBTF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -7.5 million ?
Dec. 31, 2025 914817 ?
June 30, 2025 -3.7 million 2.7 million
Dec. 31, 2024 2.9 million 2.2 million

CSBTF Net Income

No data available :(

CSBTF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 7.8 million - -
Dec. 31, 2025 15.7 million - 1.4 million
June 30, 2025 17.9 million - 1.8 million
Dec. 31, 2024 17.5 million - 1.8 million

CSBTF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 39.5 million
Dec. 31, 2025 40.0 million
June 30, 2025 40.3 million
Dec. 31, 2024 37.2 million

CSBTF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 5.3 million 5.6 million - -
Dec. 31, 2025 1.0 million 5.1 million - -
June 30, 2025 1.1 million 4.3 million 11.1 million 37.4 million
Dec. 31, 2024 515000 3.4 million -1.9 million 17.7 million

CSBTF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 72.3 million 10.7 million
Dec. 31, 2025 66.1 million 9.7 million
June 30, 2025 63.5 million 7.1 million
Dec. 31, 2024 43.7 million 10.0 million

CSBTF

Price: $26.99

52 week price:
22.72
42.81

Earnings Per Share: 0.23 USD

P/E Ratio: 117.35

Exchange: PNK

Sector: Healthcare

Industry: Medical Devices

Market Capitalization: 1.1 billion

Links: